Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consequences of CT colonography in stenosing colorectal cancer.
Huisman JF, Leicher LW, de Boer E, van Westreenen HL, de Groot JW, Holman FA, van de Meeberg PC, Sallevelt P, Peeters K, Wasser M, Vasen H, de Vos Tot Nederveen Cappel WH. Huisman JF, et al. Among authors: de groot jw, de vos tot nederveen cappel wh, de boer e. Int J Colorectal Dis. 2017 Mar;32(3):367-373. doi: 10.1007/s00384-016-2683-6. Epub 2016 Oct 25. Int J Colorectal Dis. 2017. PMID: 27783161
Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret.
Meyer VM, Meuzelaar RR, Schoenaker Y, de Groot JW, de Boer E, Reerink O, de Vos Tot Nederveen Cappel W, Beets GL, van Westreenen HL. Meyer VM, et al. Among authors: de vos tot nederveen cappel w, de groot jw, de boer e. Cancers (Basel). 2021 Feb 11;13(4):742. doi: 10.3390/cancers13040742. Cancers (Basel). 2021. PMID: 33670120 Free PMC article.
Taste alterations and cancer treatment.
van Oort S, Kramer E, de Groot JW, Visser O. van Oort S, et al. Among authors: de groot jw. Curr Opin Support Palliat Care. 2018 Jun;12(2):162-167. doi: 10.1097/SPC.0000000000000346. Curr Opin Support Palliat Care. 2018. PMID: 29570496 Review.
Informal caregiver well-being during and after patients' treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study.
Langenberg SMCH, Poort H, Wymenga ANM, de Groot JW, Muller EW, van der Graaf WTA, Prins JB, van Herpen CML. Langenberg SMCH, et al. Among authors: de groot jw. Support Care Cancer. 2021 May;29(5):2481-2491. doi: 10.1007/s00520-020-05738-w. Epub 2020 Sep 15. Support Care Cancer. 2021. PMID: 32935205 Free PMC article.
Prospective practice survey of management of cetuximab-related skin reactions.
Lugtenberg RT, Boers-Doets CB, Witteveen PO, van Herpen CML, Wymenga ANM, de Groot JWB, Hoeben A, Del Grande C, van Doorn B, Koldenhof JJ, Driessen CML, Gelderblom H. Lugtenberg RT, et al. Support Care Cancer. 2021 Jul;29(7):3497-3506. doi: 10.1007/s00520-020-05862-7. Epub 2020 Nov 4. Support Care Cancer. 2021. PMID: 33150521 Free PMC article.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, de Groot JWWB, Hospers GAP, Kapiteijn E, Bloem M, Piersma D, Stevense-den Boer M, Verheijden RJ, van der Veldt AAM, Wouters MWJM, Blokx WAM, Suijkerbuijk KPM. Van Not OJ, et al. Cancer. 2024 May 1;130(9):1673-1683. doi: 10.1002/cncr.35178. Epub 2024 Jan 10. Cancer. 2024. PMID: 38198485
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study.
Biesma NC, Graus MUJE, Cirkel GA, Besselink MG, de Groot JWB, Koerkamp BG, Herbschleb KH, Los M, Verdonk RC, Wilmink JW, Cervantes A, Valle JW, Valkenburg-van Iersel LBJ, Froeling FEM, Molenaar IQ, Daamen LA, de Vos-Geelen J, van Santvoort HC; Dutch Pancreatic Cancer Group. Biesma NC, et al. Among authors: de groot jwb. Eur J Surg Oncol. 2024 Dec 12;51(3):109544. doi: 10.1016/j.ejso.2024.109544. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39689462 Free article.
A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.
Schadendorf D, Dummer R, Flaherty KT, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsová I, Liszkay L, Loquai C, Mandalà M, Yamazaki N, Queirolo P, Guenzel C, Polli A, Thakur M, di Pietro A, Ascierto PA. Schadendorf D, et al. Among authors: de groot jwb. Future Oncol. 2025 Jan 14:1-12. doi: 10.1080/14796694.2024.2442851. Online ahead of print. Future Oncol. 2025. PMID: 39810544
223 results